Cubist Systematic Strategies’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-77,692
| Closed | -$2.98M | – | 4200 |
|
|
2023
Q2 | $2.98M | Buy |
77,692
+74,662
| +2,464% | +$1.92M | 0.02% | 1181 |
|
|
2023
Q1 | $70.1K | Sell |
3,030
-28,858
| -90% | -$688K | ﹤0.01% | 3507 |
|
|
2022
Q4 | $835K | Sell |
31,888
-27,613
| -46% | -$612K | ﹤0.01% | 2617 |
|
|
2022
Q3 | $1.17M | Sell |
59,501
-100,558
| -63% | -$2.02M | 0.01% | 2493 |
|
|
2022
Q2 | $2.8M | Buy |
160,059
+158,409
| +9,601% | +$2.49M | 0.02% | 1540 |
|
|
2022
Q1 | $27K | Sell |
1,650
-55,801
| -97% | -$759K | ﹤0.01% | 3458 |
|
|
2021
Q4 | $937K | Buy |
+57,451
| New | +$818K | 0.01% | 1966 |
|
|
2021
Q3 | – | Sell |
-1,991
| Closed | -$28K | – | 3254 |
|
|
2021
Q2 | $28K | Buy |
+1,991
| New | +$31.8K | ﹤0.01% | 2835 |
|
|
2021
Q1 | – | Sell |
-379
| Closed | -$6K | – | 3018 |
|
|
2020
Q4 | $6K | Buy |
379
+267
| +238% | +$4.03K | ﹤0.01% | 2526 |
|
|
2020
Q3 | $1K | Buy |
+112
| New | +$1.5K | ﹤0.01% | 2461 |
|
|
2020
Q2 | – | Sell |
-8,241
| Closed | -$113K | – | 2571 |
|
|
2020
Q1 | $113K | Buy |
+8,241
| New | +$97.4K | ﹤0.01% | 1883 |
|
|
2019
Q2 | – | Sell |
-2,781
| Closed | -$55K | – | 2628 |
|
|
2019
Q1 | $55K | Buy |
+2,781
| New | +$48.5K | ﹤0.01% | 2092 |
|
|
2018
Q2 | – | Sell |
-60
| Closed | -$3K | – | 2122 |
|
|
2018
Q1 | $3K | Sell |
60
-2,075
| -97% | -$75.9K | ﹤0.01% | 1794 |
|
|
2017
Q4 | $80K | Buy |
2,135
+1,895
| +790% | +$82.7K | ﹤0.01% | 1720 |
|
|
2017
Q3 | $13K | Buy |
+240
| New | +$14.3K | ﹤0.01% | 1790 |
|
|
2015
Q4 | – | Sell |
-60
| Closed | -$6K | – | 2002 |
|
|
2015
Q3 | $6K | Sell |
60
-186
| -76% | -$22.1K | ﹤0.01% | 1819 |
|
|
2015
Q2 | $37K | Buy |
+246
| New | +$40.6K | ﹤0.01% | 1729 |
|
Cubist Systematic Strategies's KDNY Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 77,692 shares — an estimated $2.98M sold.
Cubist Systematic Strategies first reported a position in KDNY in Q2 2015 and held it in 17 quarters. The position peaked at $2.98M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Cubist Systematic Strategies reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 77,692 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.98M.
- Cubist Systematic Strategies first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Cubist Systematic Strategies's Chinook Therapeutics, Inc. Common Stock position peaked at $2.98M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.